Global /China /Healthcare /Drug Manufacturers - General /605177

Zhejiang East Asia Pharmaceutical Co., Ltd.

605177

• SSE: 605177 • Delayed

20.92CNY -0.8%

3.08 USD

As of 27 June 2026, Zhejiang East Asia Pharmaceutical Co., Ltd. has a market cap of $349.53M USD, ranking #17611 globally and #5473 in China. It ranks #1591 in the Healthcare sector, and #575 in the Drug Manufacturers - General industry.

Global Rank

17611

Country Rank

5473

Sector Rank

1591

Industry Rank

575

Key Stats

Market Cap

$349.53MUSD

2.37B CNY

Enterprise Value

$442.33MUSD

3.0B CNY

Revenue (TTM)

$138.44MUSD

940.19M CNY

EBITDA (TTM)

$17.83MUSD

121.07M CNY

Net Income (TTM)

-$12.13MUSD

-82.39M CNY

EBITDA Margin

13%

Profit Margin

-8.8%

PS Ratio

2.5

PB Ratio

1.3

EV/EBITDA

24.5

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Cheng Chi open_in_new

Employees

1,749

Founded

1998

Website

eapharm.cn open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.8%	2.5%	-1.1%	-2.2%	3.8%	18%	26%	-16%	-43%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	605177 ISIN: CNE1000077G5 Shares Out.: Shares Outstanding: 112.564M¹ Shares Float: 76.843M² TV: TradingView: SSE: 605177 SA: Stock Analysis: SHA: 605177 YF: Yahoo Finance: 605177.SS GF: Google Finance: SHA: 605177 BA: Barron's: 605177 MS: Morningstar: XSHG: 605177	20.92 CNY	TV: TradingView: SSE: 605177 SA: Stock Analysis: SHA: 605177 YF: Yahoo Finance: 605177.SS GF: Google Finance: SHA: 605177 BA: Barron's: 605177 MS: Morningstar: XSHG: 605177

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Zhejiang East Asia Pharmaceutical Co., Ltd.

Zhejiang East Asia Pharmaceutical Co., Ltd. produces and sells pharmaceutical chemicals, tablets, granules, intermediates, and capsules. It offers quinolones synthetic antibacterial agents, antifungal products, gastrointestinal medications, semi-synthetic cephalosporin antibiotics, carbapenem antibiotics, antiviral agents, central nervous system medications, respiratory drugs, antiallergic agents, antineoplastic agents and tumor adjuvant drugs, and other products. The company provides products in the fields of cardiovascular, anti-aging dementia, digestive system, diabetic neuropathy, and anti-pathogenic microorganisms. It serves customers through a sales network in Japan, South Korea, Europe, America, Southeast Asia, and internationally. Zhejiang East Asia Pharmaceutical Co., Ltd. was founded in 1998 and is headquartered in Taizhou, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.73B 364.89B CNY 15K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.53B 336.36B CNY 14K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.5B 223.48B HKD 8K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.79B 147.32B HKD 5K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.48B 111.89B CNY 5K%	-	China
Akeso, Inc. SHEK: 9926	$16.0B 125.46B HKD 4K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 218K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 156K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 103K%	97.4	United States
Roche Holding AG SIX: RO	$316.45B 256.25B CHF 90K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$284.53B 215.59B GBP 81K%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 78K%	15.1	United States

chevron_leftBack